Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication

Elkoumy, Ahmed; Jose, John; Sengottuvelu, G.; Kumar, Ajay; Srinivas, B C; Manjunath, Cholenahally Nanjappa; Ravindranath, Khandenahally Shankarappa; Parekh, Maulik; Chandra, Praveen; Kapoor, Rajneesh; Abdelshafy, Mahmoud; Seth, Ashok; Agrawal, Praveer; Mathur, A.; Rao, Ravindra Singh; Elzomor, Hesham; Sadanada, K S; Kumar, Vijay; Arsang-Jang, Shahram; Mehrotra, Sanjay; Raghuraman, Bagirath; Khanolkar, Uday; Premchand, Rajendra Kumar; Chopra, Manik; Krishna, Pravin; Mehta, Haresh; Gupta, Rahul; Kumar, Viveka; Boopathy, Nagendra; Baumbach, Andreas; Serruys, Patrick W.; Soliman, Osama

doi:10.1016/j.ijcard.2023.04.003

Cited by 8 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Myval, VitaFlow and Venus-A are promising options in the THV armamentarium. In our latest report of 103 patients receiving the new Myval Octacor THV, moderate AR was basically eliminated in patients with tricuspid valve morphology ( 28 ). Of note, although the incidence of moderate/severe AR has regressed with contemporary THV, the incidence of mild AR remains noticeable, and assessment of its long-term prognosis still requires further investigation to establish whether it has a benign or malignant outcome and whether further refinements (e.g., outside skirt expanding with moisture) of THV will be able to eliminate para valvular regurgitation.…”

Section: Comparison Of Aortic Regurgitation Following Different Tavr ...mentioning

confidence: 99%

Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement

Abdelshafy,

Serruys,

Tsai

et al. 2023

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

Paravalvular leak (PVL) is a shortcoming that can erode the clinical benefits of transcatheter valve replacement (TAVR) and therefore a readily applicable method (aortography) to quantitate PVL objectively and accurately in the interventional suite is appealing to all operators. The ratio between the areas of the time-density curves in the aorta and left ventricular outflow tract (LVOT-AR) defines the regurgitation fraction (RF). This technique has been validated in a mock circulation; a single injection in diastole was further tested in porcine and ovine models. In the clinical setting, LVOT-AR was compared with trans-thoracic and trans-oesophageal echocardiography and cardiac magnetic resonance imaging. LVOT-AR > 17% discriminates mild from moderate aortic regurgitation on echocardiography and confers a poor prognosis in multiple registries, and justifies balloon post-dilatation. The LVOT-AR differentiates the individual performances of many old and novel devices and is being used in ongoing randomized trials and registries.

show abstract

Section: Comparison Of Aortic Regurgitation Following Different Tavr ...mentioning

confidence: 99%

Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement

Abdelshafy,

Serruys,

Tsai

et al. 2023

Front. Cardiovasc. Med.

Self Cite

View full text Add to dashboard Cite

show abstract

Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis — A real-world Indian experience (The OCTACOR India Study)

Jose,

Mandalay,

Cholenahally

et al. 2024

Cardiovascular Revascularization Medicine

View full text Add to dashboard Cite

Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis

Moscarella,

Ielasi,

Montonati

et al. 2024

International Journal of Cardiology

View full text Add to dashboard Cite

Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication

Cited by 8 publications

References 24 publications

Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement

Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacement

Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis — A real-world Indian experience (The OCTACOR India Study)

Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis

Contact Info

Product

Resources

About